Case reports cover hepatitis B reactivation, colitis, black esophagus
These gastroenterology and hepatology topics were touched upon in recent cases.
Several gastroenterology and hepatology topics were covered in cases published Nov. 5 by Annals of Internal Medicine: Clinical Cases.
One case described an 83-year-old man who received an allogenic stem-cell transplant for acute myelogenous leukemia in 2010 and had mild COVID-19 illness in 2023, after which elevated serum aminotransferase levels were noted. He tested positive for hepatitis B virus, highlighting the risk of reactivation after COVID-19.
Another case reported on a 26-year-old patient who received carbamazepine for epilepsy and then presented with toxic epidermal necrolysis as well as severe acute colitis, successfully treated with infliximab.
The third case described a 69-year-old man with uncontrolled type 2 diabetes who was found to have black esophagus, also known as acute esophageal necrosis and Gurvits syndrome, a rare medical condition characterized by a striking endoscopic appearance of diffuse black discoloration of the esophageal mucosa.